These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6311007)

  • 41. [Absorption, distribution, metabolism and excretion of bacmecillinam. IV. Metabolites of bacmecillinam in human urine].
    Kobayashi S; Inoue A
    Jpn J Antibiot; 1985 Apr; 38(4):1113-6. PubMed ID: 4032724
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Factors influencing the absorption and disposition of mecillinam and pivmecillinam in man.
    Andrews J; Kendall MJ; Mitchard M
    Br J Clin Pharmacol; 1976 Aug; 3(4):627-32. PubMed ID: 22216505
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetics and bioavailability of diacetolol, the main metabolite of acebutolol.
    Flouvat B; Roux A; Chau NP; Viallet M; Andre-Fouet X; Woehrle R; Gregoire J
    Eur J Clin Pharmacol; 1981 Mar; 19(4):287-92. PubMed ID: 7286031
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics and bioavailability of sultamicillin estimated by high performance liquid chromatography.
    ROgers HJ; Bradbrook ID; Morrison PJ; Spector RG; Cox DA; Lees LJ
    J Antimicrob Chemother; 1983 May; 11(5):435-45. PubMed ID: 6307964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mecillinam in patients on haemodialysis.
    Bailey K; Cruickshank JG; Bisson PG; Radford BL
    Br J Clin Pharmacol; 1980 Aug; 10(2):177-80. PubMed ID: 6252916
    [No Abstract]   [Full Text] [Related]  

  • 47. Pharmacokinetics of bacampicillin and bacmecillinam in plasma and peripheral lymph.
    Bergan T; Engeset A; Olszewski W; Solberg R
    Lymphology; 1979 Jun; 12(2):85-94. PubMed ID: 226808
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The bioavailability and pharmacokinetics of slow release nifedipine during chronic dosing in volunteers.
    Debbas NM; Jackson SH; Shah K; Abrams SM; Johnston A; Turner P
    Br J Clin Pharmacol; 1986 Apr; 21(4):385-8. PubMed ID: 3707812
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cefetamet pivoxil clinical pharmacokinetics.
    Blouin RA; Stoeckel K
    Clin Pharmacokinet; 1993 Sep; 25(3):172-88. PubMed ID: 8222459
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Pharmacokinetic studies of micronomicin using a continuous intravenous infusion method].
    Yamasaku F
    Jpn J Antibiot; 1983 Nov; 36(11):3283-90. PubMed ID: 6674541
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Chemotherapy of bile duct infections. VI. Excretion of pivmecillinam into bile, and its clinical effect (author's transl)].
    Tanimura H; Takenaka M; Maruyama K; Setoyama M; Mukaihara S; Hikasa Y; Izukura T; Fujii K; Yasumoto Y; Sekiya T; Hara Y; Kawaguchi H; Hanabusa S; Murayama Y; Maki Y; Nakajima K; Kataoka S; Sato T; Henmi K; Kikuchi S; Takatsuki H; Shirai O; Fujiwara N; Arioka K
    Jpn J Antibiot; 1979 Aug; 32(8):819-29. PubMed ID: 226737
    [No Abstract]   [Full Text] [Related]  

  • 54. [Pivmecillinam (Selexid)].
    Jensen G
    Ugeskr Laeger; 1978 Apr; 140(16):925-6. PubMed ID: 206996
    [No Abstract]   [Full Text] [Related]  

  • 55. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Treatment of acute urinary infections. Comparison between pivmecillinam for 3 days and sulfamethizole therapy for 6 days].
    Bitsch M; Hansen PH; Pagh J
    Ugeskr Laeger; 1985 Apr; 147(17):1392-5. PubMed ID: 4002410
    [No Abstract]   [Full Text] [Related]  

  • 57. A study of the biliary excretion of mecillinam in patients with biliary disease.
    Hares MM; Hegarty A; Tomkyns J; Burdon DW; Keighley MR
    J Antimicrob Chemother; 1982 Mar; 9(3):217-22. PubMed ID: 6281228
    [No Abstract]   [Full Text] [Related]  

  • 58. Human pharmacokinetics of tolfenamic acid, a new anti-inflammatory agent.
    Pentikäinen PJ; Neuvonen PJ; Backman C
    Eur J Clin Pharmacol; 1981; 19(5):359-65. PubMed ID: 7238564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bioavailability, pharmacokinetics, and clinical effects of an oral preparation of etoposide.
    Stewart DJ; Nundy D; Maroun JA; Tetreault L; Prior J
    Cancer Treat Rep; 1985 Mar; 69(3):269-73. PubMed ID: 3884152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Absorption, distribution, metabolism and excretion of bacmecillinam. I. Absorption, distribution, metabolism and excretion of 14C-bacmecillinam following oral administration to rats].
    Kobayashi S; Inoue A; Deguchi T
    Jpn J Antibiot; 1985 Apr; 38(4):1093-101. PubMed ID: 4032721
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.